Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Return on Equity (2016 - 2026)

Ocular Therapeutix has reported Return on Equity over the past 13 years, most recently at 0.0% for Q1 2026.

  • For Q1 2026, Return on Equity changed 0.0% year-over-year to 0.0%; the TTM value through Mar 2026 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.01%, 0.0% changed from the prior year.
  • Return on Equity for Q1 2026 was 0.0% at Ocular Therapeutix, up from 0.01% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.0% in Q2 2024 and troughed at 0.16% in Q3 2023.
  • A 5-year average of 0.03% and a median of 0.01% in 2025 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: fell -15bps in 2023 and later grew 16bps in 2024.
  • Year by year, Return on Equity stood at 0.02% in 2022, then grew by 13bps to 0.02% in 2023, then surged by 73bps to 0.0% in 2024, then fell by -17bps to 0.01% in 2025, then increased by 19bps to 0.0% in 2026.
  • Business Quant data shows Return on Equity for OCUL at 0.0% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.